![](/img/cover-not-exists.png)
Randomized, Double Blind, Placebo-Controlled Trial of a TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) After Allogeneic Stem Cell Transplant (SCT). A Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study
Yanik, Gregory, Ho, Vincent T., Horowitz, Mary, Weisdorf, Daniel J., Logan, Brent R., Wu, Juan, Soiffer, Robert J., Wingard, John R., Levine, John E., Ferrara, James L.M., Giralt, Sergio A., White, ErVolume:
19
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2012.11.141
Date:
February, 2013
File:
PDF, 53 KB
english, 2013